STOK stock will be listed today, IPOing at $18, market cap of ~$550mm.  They have a drug for treating Dravet Syndrome which is in in Phase 3 trials.

Show notes:

~greetings and salutations~

$STOK: Stroke Therapeutics

$ADBE: Adobe

$AXTA: Axalta Coating

~intermission~

$IRWD: Ironwood Pharma

$MLNT: Melinta

~fin~